Quiroga J, Rodríguez-Sanromán J L, Guarner F, Rodríguez Ortigosa C, Aréjola J M, Prieto J
Department of Internal Medicine, University Clinic of Navarra, Pamplona, Spain.
J Hepatol. 1991 May;12(3):302-11. doi: 10.1016/0168-8278(91)90831-u.
Lipoxygenase arachidonic acid metabolites mediate secretory processes in several tissues, but their possible involvement in liver transport functions is still unknown. This study evaluated the influence of the lipoxygenase inhibitor nordihydroguayaretic acid (NDGA), the cyclooxygenase inhibitor indomethacin (INDO), and the dual cyclo and lipoxygenase inhibitors 3-amino-1-[m-(trifluoromethyl)-phenyl]-2-pyrazoline (BW 755c) and eicosatetraynoic acid (ETYA) on the handling of glycocholic acid (GC) by isolated rat hepatocytes. No drug modified cell viability or oxygen consumption in hepatocytes. In 30-min incubations with 50 microM GC the initial rate of GC uptake (V0) in control hepatocytes was 1.15 +/- 0.09 nmol.mg protein-1.min-1. The cellular GC content remained constant from 10 to 30 min (steady-state phase), the 30-min value being 6.63 +/- 0.35 nmol.mg protein-1. NDGA (10-50 microM), BW 755c (25-200 microM) and ETYA (5-100 microM), prevented the steady-state phase occurring, thus determining a progressive accumulation of GC in cells with time. As compared to controls, 50 microM NDGA (+37%, p less than 0.01), 200 microM BW 755c (+39%, p less than 0.01) and 5 microM ETYA (+19%, p less than 0.05) induced the highest increases in the amount of GC in cells at 30 min, in all cases V0 being unchanged. Concentrations of BW 755c and ETYA above those indicated also decreased V0. Both V0 and the amount of cellular GC in the steady-state phase were proportionally decreased by high INDO concentrations (25-100 microM) which did not modify the morphology of the uptake curve. Since experiments with dual and lipoxygenase inhibitors suggested an impairment of GC efflux, the initial rate of GC efflux (V0ef) was measured in hepatocytes preloaded with 50 microM GC and transferred to a GC-free medium. In controls, V0ef was 1.12 +/- 0.12 nmol.mg protein-1.min-1. BW 755c (200 microM) and NDGA (50 microM) reduced V0ef by 45 and 38%, respectively. The kinetic analysis of the effect of 200 microM BW 755c on the efflux process using hepatocytes preloaded with GC from 5 to 200 microM disclosed a non-competitive inhibition. Vmax was reduced from 1.37 +/- 0.15 to 0.89 +/- 0.10 (p less than 0.01), whereas Km was unchanged (3.79 +/- 0.33 vs. 4.25 +/- 0.54, N.S.). In summary, inhibitors of the lipoxygenase arachidonic acid pathway impaired the efflux of GC from isolated rat hepatocytes. The hypothesis is raised that oxidized metabolites of arachidonic acid may participate on the secretion of bile salts in these cells.
脂氧合酶花生四烯酸代谢产物介导多种组织中的分泌过程,但其是否参与肝脏转运功能仍不清楚。本研究评估了脂氧合酶抑制剂去甲二氢愈创木酸(NDGA)、环氧化酶抑制剂吲哚美辛(INDO)以及环氧化酶和脂氧合酶双重抑制剂3-氨基-1-[间-(三氟甲基)-苯基]-2-吡唑啉(BW 755c)和二十碳四烯酸(ETYA)对分离的大鼠肝细胞处理甘氨胆酸(GC)的影响。没有药物改变肝细胞的活力或耗氧量。在与50μM GC孵育30分钟时,对照肝细胞中GC摄取的初始速率(V0)为1.15±0.09 nmol·mg蛋白-1·min-1。细胞内GC含量在10至30分钟(稳态期)保持恒定,30分钟时的值为6.63±0.35 nmol·mg蛋白-1。NDGA(10 - 50μM)、BW 755c(25 - 200μM)和ETYA(5 - 100μM)阻止了稳态期的出现,从而导致GC在细胞内随时间逐渐积累。与对照相比,50μM NDGA(增加37%,p<0.01)、200μM BW 755c(增加39%,p<0.01)和5μM ETYA(增加19%,p<0.05)在30分钟时诱导细胞内GC量增加最多,在所有情况下V0均未改变。高于上述浓度的BW 755c和ETYA也降低了V0。高浓度INDO(25 - 100μM)使V0和稳态期细胞内GC量成比例降低,且未改变摄取曲线的形态。由于双重抑制剂和脂氧合酶抑制剂的实验提示GC外排受损,因此在预先加载50μM GC并转移至无GC培养基的肝细胞中测量了GC外排的初始速率(V0ef)。在对照中,V0ef为1.12±0.12 nmol·mg蛋白-1·min-1。BW 755c(200μM)和NDGA(50μM)分别使V0ef降低45%和38%。使用预先加载5至200μM GC的肝细胞对200μM BW 755c对外排过程的影响进行动力学分析,结果显示为非竞争性抑制。Vmax从1.37±0.15降至0.89±0.10(p<0.01),而Km未改变(3.79±0.33对4.25±0.54,无显著性差异)。总之,脂氧合酶花生四烯酸途径的抑制剂损害了分离的大鼠肝细胞中GC的外排。由此提出假说:花生四烯酸的氧化代谢产物可能参与这些细胞中胆盐的分泌。